
Jul 17, 2026
Argenx Partners With Chai Discovery for AI Antibody...
Chai Discovery has partnered with argenx to leverage AI for antibody discovery, marking a significant advancement in the life sciences sector.Chai Discovery, based in San Francisco, has formed a collaboration with argenx, providing the immunology firm with early access to its generative AI platform aimed at de novo antibody discovery. This partnership is notable as it is the fourth disclosed collaboration for Chai within a span of seven months, following similar agreements with major pharmaceuti









